Older people with schizophrenia who are treated with long-acting injectable antipsychotics (LAIs) ar...

Treating patients with bipolar I disorder with a once-monthly long-acting injectable (LAI) form of a...

Last year, results from a phase 3 clinical trial showed the long-acting injectable aripiprazole laur...

The FDA has approved Invega Trinza (paliperidone palmitate), a long-acting atypical antipsychotic in...

With studies showing schizophrenia to be treatment refractory in one-fifth of those affected, psychi...